Page 117 - 2023-01-中国全科医学

·112· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn January 2023, Vol.26 No.1

optimal screening program for unknown atrial fibrillation：a cost- ［20］DIAMANTOPOULOS A，SAWYER L M，LIP G Y，et al. Cost-
effectiveness analysis［J］. Europace，2017，19（10）：1650- effectiveness of an insertable cardiac monitor to detect atrial
1656. DOI：10.1093/europace/eux002. fibrillation in patients with cryptogenic stroke［J］. Int J Stroke，
［10］HILL N R，SANDLER B，MOKGOKONG R，et al. Cost- 2016，11（3）：302-312. DOI：10.1177/1747493015620803.
effectiveness of targeted screening for the identification of patients ［21］MAERVOET J，BOSSERS N，BORGE R P J，et al. Use of
with atrial fibrillation：evaluation of a machine learning risk insertable cardiac monitors for the detection of atrial fibrillation in
prediction algorithm［J］. J Med Econ，2020，23（4）：386- patients with cryptogenic stroke in the United States is cost-effective
393. DOI：10.1080/13696998.2019.1706543. ［J］. J Med Econ，2019，22（11）：1221-1234. DOI：
［11］MORAN P S，TELJEUR C，HARRINGTON P，et al. Cost- 10.1080/13696998.2019.1663355.
effectiveness of a national opportunistic screening program for atrial ［22］MAIRESSE G H，MORAN P，VAN GELDER I C，et al. Screening
fibrillation in Ireland［J］. Value Heal，2016，19（8）：985- for atrial fibrillation：a European Heart Rhythm Association（EHRA）
995. DOI：10.1016/j.jval.2016.07.007. consensus document endorsed by the Heart Rhythm Society（HRS），
［12］卢莎，孙金悦，樊重俊 . 决策树 - 马尔可夫模型在心房颤动筛 Asia Pacific Heart Rhythm Society（APHRS），and Sociedad
查经济学评价中的应用［J］. 上海理工大学学报，2022，44（3）： Latinoamericana de EstimulaciónCardíaca y Electrofisiología
308-314. DOI：10.13255/j.cnki.jusst.20210808001. （SOLAECE）［J］. Europace，2017，19（10）：1589-1623.
LU S，SUN J Y，FAN C J. Application of decision tree-Markov DOI：10.1093/europace/eux177.
model in economic evaluation of atrial fibrillation screening ［23］GORENEK B，BAX J，BORIANI G，et al. Device-detected
［J］. Journal of University of Shanghai for Science and subclinical atrial tachyarrhythmias：definition，implications and
Technology，2022，44（3）：308-314. DOI：10.13255/j.cnki. management：an European Heart Rhythm Association（EHRA）
jusst.20210808001. consensus document，endorsed by Heart Rhythm Society（HRS），
［13］PROIETTI M，FARCOMENI A，GOETHALS P，et al. Cost- Asia Pacific Heart Rhythm Society（APHRS）and Sociedad
effectiveness and screening performance of ECG handheld machine Latinoamericana de EstimulacionCardiaca y Electrofisiologia
in a population screening programme：the Belgian Heart Rhythm （SOLEACE）［J］. Europace，2018，20（4）：658. DOI：
Week screening programme［J］. Eur J PrevCardiol，2019，26（9）： 10.1093/europace/eux339.
964-972. DOI：10.1177/2047487319839184. ［24］BRIEGER D，AMERENA J，ATTIA J R，et al. National Heart
［14］MCINTYRE W F，YONG J H E，SANDHU R K，et al. Prevalence Foundation of Australia and Cardiac Society of Australia and New
of undiagnosed atrial fibrillation in elderly individuals and potential Zealand：Australian clinical guidelines for the diagnosis and
cost-effectiveness of non-invasive ambulatory electrocardiographic management of atrial fibrillation 2018［J］. Med J Aust，2018，
screening：the ASSERT- Ⅲ study［J］. J Electrocardiol，2020， 209（8）：356-362. DOI：10.5694/mja18.00646.
58：56-60. DOI：10.1016/j.jelectrocard.2019.11.040. ［25］JOUNG B，LEE J M，LEE K H，et al. 2018 Korean guideline of
［15］DESTEGHE L，RAYMAEKERS Z，LUTIN M，et al. Performance atrial fibrillation management［J］. Korean Circ J，2018，48（12）：
of handheld electrocardiogram devices to detect atrial fibrillation in a 1033-1080. DOI：10.4070/kcj.2018.0339.
cardiology and geriatric ward setting［J］. Europace，2017，19（1）： ［26］ANDRADE J G，AGUILAR M，ATZEMA C，et al. The 2020
29-39. DOI：10.1093/europace/euw025. Canadian Cardiovascular Society/Canadian Heart Rhythm Society
［16］OGUZ M，LANITIS T，LI X Y，et al. Cost-effectiveness of comprehensive guidelines for the management of atrial fibrillation［J］.
extended and one-time screening versus no screening for non- Can J Cardiol，2020，36（12）：1847-1948. DOI：10.1016/
valvular atrial fibrillation in the USA［J］. Appl Health Econ Health j.cjca.2020.09.001.
Policy，2020，18（4）：533-545. DOI：10.1007/s40258-019- ［27］Clinical practice of insertable cardiac monitor：a consensus of
00542-y. Chinese experts（2020）［J］. Chinese Journal of Cardiac
［17］ORCHARD J，LI J L，FREEDMAN B，et al. Atrial fibrillation Arrhythmias，2020，24（6）：545-555. DOI：10.3760/cma.
screen，management，and guideline-recommended therapy in j.cn.113859-20201010-00259.
the rural primary care setting：a cross-sectional study and cost- ［28］中华医学会神经病学分会 . 中国脑血管病一级预防指南 2019
effectiveness analysis of eHealth tools to support all stages of ［J］. 中 华 神 经 科 杂 志，2019，52（9）：684-709. DOI：
screening［J］. J Am Heart Assoc，2020，9（18）：e017080. 10.3760/cma.j.issn.1006-7876.2019.09.002.
DOI：10.1161/JAHA.120.017080. Chinese Society of Neurology. Guidelines for the primary prevention
［18］SAWYER L M，WITTE K K，REYNOLDS M R，et al. Cost- of cerebrovascular diseases in China 2019［J］. Chinese Journal
effectiveness of an insertable cardiac monitor to detect atrial of Neurology，2019，52（9）：684-709. DOI：10.3760/cma.
fibrillation in patients with cryptogenic stroke［J］. J Comp Eff j.issn.1006-7876.2019.09.002.
Res，2021，10（2）：127-141. DOI：10.2217/cer-2020-0224. ［29］中华医学会心电生理和起搏分会，中国医师协会心律学专业
［19］YONG J H E，THAVORN K，HOCH J S，et al. Potential cost- 委员会 . 植入型心电监测仪临床应用 2020 年中国专家共识
effectiveness of ambulatory cardiac rhythm monitoring after ［J］. 中华心律失常学杂志，2020，24（6）：545-555. DOI：
cryptogenic stroke［J］. Stroke，2016，47（9）：2380-2385. 10.3760/cma.j.cn.113859-20201010-00259.
DOI：10.1161/STROKEAHA.115.011979. （下转第 117 页）